• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lipids in women: screening and treatment.

作者信息

Walsh Judith M E

机构信息

Division of General Internal Medicine, Department of Medicine, University of California, San Francisco 94115, USA.

出版信息

J Am Med Womens Assoc (1972). 2003 Fall;58(4):240-7.

PMID:14640255
Abstract

Hyperlipidemia is a risk factor for coronary heart disease (CHD) in both men and women, although the association between total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and CHD risk differs in men and women. Although several clinical trials of lipid lowering for both primary and secondary prevention of CHD have been conducted, women have not always been included, have been included in small numbers, or have not had their results analyzed separately. CHD risk assessment is an important component of decision making about screening and treatment of hyperlipidemia. This article presents guidelines for screening and treatment of hyperlipidemia in women with CHD, in healthy women, and in women at risk for CHD.

摘要

相似文献

1
Lipids in women: screening and treatment.
J Am Med Womens Assoc (1972). 2003 Fall;58(4):240-7.
2
Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study.降胆固醇一级预防试验在普通人群中的适用性:弗明汉心脏研究
Arch Intern Med. 2001 Apr 9;161(7):949-54. doi: 10.1001/archinte.161.7.949.
3
A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.冠心病的高风险评分与40岁男性和女性的代谢综合征相关。
J Cardiovasc Risk. 2003 Apr;10(2):129-35. doi: 10.1097/01.hjr.0000060837.46105.e7.
4
Cholesterol: precursor to many lipid disorders.胆固醇:多种脂质紊乱的前体。
Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98.
5
Lipid abnormalities in women: data for risk, data for management.女性脂质异常:风险数据与管理数据
Cardiol Rev. 2006 Nov-Dec;14(6):276-80. doi: 10.1097/01.crd.0000240528.66999.ed.
6
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.与冠心病相比,女性中C反应蛋白和血脂水平作为缺血性中风决定因素的相对强度。
J Am Coll Cardiol. 2006 Dec 5;48(11):2235-42. doi: 10.1016/j.jacc.2006.09.030. Epub 2006 Nov 13.
7
Hiding unhealthy heart outcomes in a low-fat diet trial: the Women's Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if they consumed a low-fat 'heart-healthy' diet.在低脂饮食试验中隐藏不良心脏结局:女性健康倡议随机对照饮食改良试验发现,患有已确诊冠心病的绝经后妇女,如果食用低脂“心脏健康”饮食,发生不良结局的风险会增加。
Open Heart. 2021 Jul;8(2). doi: 10.1136/openhrt-2021-001680.
8
Addressing cardiovascular disease in women: focus on dyslipidemia.关注女性心血管疾病:聚焦血脂异常
J Am Board Fam Pract. 2004 Nov-Dec;17(6):424-37. doi: 10.3122/jabfm.17.6.424.
9
[Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].[根据国际动脉粥样硬化学会的建议进行血脂异常治疗以预防冠心病]
Przegl Lek. 1999;56(5):372-6.
10
Optimal management of dyslipidemia in women and men.男女血脂异常的最佳管理
J Gend Specif Med. 1999 Nov-Dec;2(6):37-42.

引用本文的文献

1
Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study.设计并实施两种高质量 CHD 预防策略的比较效果研究:心脏健康研究的方法和参与者特征。
Contemp Clin Trials. 2013 Nov;36(2):394-405. doi: 10.1016/j.cct.2013.07.013. Epub 2013 Aug 2.